A. Gaddi

5.2k total citations · 1 hit paper
119 papers, 3.7k citations indexed

About

A. Gaddi is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A. Gaddi has authored 119 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Surgery, 29 papers in Endocrinology, Diabetes and Metabolism and 20 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A. Gaddi's work include Lipoproteins and Cardiovascular Health (29 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and Antioxidant Activity and Oxidative Stress (12 papers). A. Gaddi is often cited by papers focused on Lipoproteins and Cardiovascular Health (29 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers) and Antioxidant Activity and Oxidative Stress (12 papers). A. Gaddi collaborates with scholars based in Italy, Spain and United States. A. Gaddi's co-authors include Arrigo F.G. Cicero, Giuseppe Derosa, Claudio Borghi, Simona Nascetti, Henrik E. Poulsen, María‐Isabel Covas, Ada Dormi, H. Kiesewetter, Jari Kaikkonen and Leonardina Ciccarelli and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

A. Gaddi

113 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Effect of Polyphenols in Olive Oil on Heart Disease Risk Factors

2006 560 citations María‐Isabel Covas, Kristiina Nyyssönen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Gaddi Italy	35	977	960	790	775	583	119	3.7k
Marek Naruszewicz Poland	33	785 0.8×	414 0.4×	633 0.8×	969 1.3×	253 0.4×	140	3.5k
Gianna Ferretti Italy	41	1.0k 1.1×	739 0.8×	952 1.2×	1.1k 1.4×	120 0.2×	155	5.6k
Guillermo T. Sáez Spain	42	759 0.8×	458 0.5×	1.2k 1.6×	1.5k 1.9×	634 1.1×	132	5.9k
Natalie C. Ward Australia	42	784 0.8×	881 0.9×	845 1.1×	1.4k 1.8×	228 0.4×	129	5.5k
Hamid Nasri Iran	38	654 0.7×	1.2k 1.2×	615 0.8×	1.0k 1.3×	143 0.2×	350	6.1k
Dawn C. Schwenke United States	35	1.5k 1.5×	2.0k 2.1×	707 0.9×	1.6k 2.1×	236 0.4×	83	5.8k
Jari Kaikkonen Finland	32	543 0.6×	293 0.3×	1.1k 1.4×	637 0.8×	796 1.4×	49	3.4k
Tonino Bucciarelli Italy	31	393 0.4×	348 0.4×	508 0.6×	915 1.2×	283 0.5×	84	3.4k
Luciano Cominacini Italy	40	713 0.7×	647 0.7×	475 0.6×	1.2k 1.6×	172 0.3×	127	4.8k
Cristina Nocella Italy	38	699 0.7×	397 0.4×	530 0.7×	1.1k 1.4×	239 0.4×	122	4.6k

Countries citing papers authored by A. Gaddi

Since Specialization

Citations

This map shows the geographic impact of A. Gaddi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Gaddi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Gaddi more than expected).

Fields of papers citing papers by A. Gaddi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Gaddi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Gaddi. The network helps show where A. Gaddi may publish in the future.

Co-authorship network of co-authors of A. Gaddi

This figure shows the co-authorship network connecting the top 25 collaborators of A. Gaddi. A scholar is included among the top collaborators of A. Gaddi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Gaddi. A. Gaddi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gaddi, A. & Marialuisa Lugaresi. (2024). Telemedicine: a unique, univocal, and shared definition for everyone. 4(1). 37–43. 3 indexed citations

Cianciosi, Danila, A. Gaddi, Lingmin Tian, et al.. (2023). Can alpha‐linolenic acid be a modulator of “cytokine storm,” oxidative stress and immune response in SARS‐CoV‐2 infection?. SHILAP Revista de lepidopterología. 5(1). 73–93. 3 indexed citations

Gaddi, A., et al.. (2016). EFFICACY AND SAFETY OF RIFAXIMIN IN ACUTE GASTROENTERITIS IN CHILDREN: A META-ANALYSIS. International Education and Research Journal. 2(3). 1 indexed citations

Castañer, Olga, Montserrat Fitó, M. Carmen López‐Sabater, et al.. (2011). The effect of olive oil polyphenols on antibodies against oxidized LDL. A randomized clinical trial. Clinical Nutrition. 30(4). 490–493. 45 indexed citations

Poluzzi, Elisabetta, Monica Lanzoni, Domenico Motola, et al.. (2008). Adherence to statin therapy and patients’ cardiovascular risk: a pharmacoepidemiological study in Italy. European Journal of Clinical Pharmacology. 64(4). 425–432. 33 indexed citations

Gaddi, A., et al.. (2007). Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date. SHILAP Revista de lepidopterología. 38 indexed citations

Gaddi, A., et al.. (2007). Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date.. PubMed Central. 57 indexed citations

Cicero, Arrigo F.G., Giuseppe Derosa, Marco Manca, et al.. (2007). Different Effect of Psyllium and Guar Dietary Supplementation on Blood Pressure Control in Hypertensive Overweight Patients: A Six-Month, Randomized Clinical Trial. Clinical and Experimental Hypertension. 29(6). 383–394. 59 indexed citations

Derosa, Giuseppe, A. Gaddi, Mario N. Piccinni, et al.. (2005). Antithrombotic Effects of Rosiglitazone‐Metformin versus Glimepiride‐Metformin Combination Therapy in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 25(5). 637–645. 21 indexed citations

10.

Gaddi, A. & Arrigo F.G. Cicero. (2005). [Treatment of peripheral obstructive artery disease: a battle that could be winned also with drugs?].. PubMed. 53(6). 605–10. 3 indexed citations

11.

Menotti, Alessandro, Mariapaola Lanti, Enrico Agabiti‐Rosei, et al.. (2005). Riskard 2005. New tools for prediction of cardiovascular disease risk derived from Italian population studies. Nutrition Metabolism and Cardiovascular Diseases. 15(6). 426–440. 41 indexed citations

12.

Cicero, Arrigo F.G., Giuseppe Derosa, & A. Gaddi. (2004). What do herbalists suggest to diabetic patients in order to improve glycemic control? Evaluation of scientific evidence and potential risks. Acta Diabetologica. 41(3). 91–98. 51 indexed citations

13.

Derosa, Giuseppe, Arrigo F.G. Cicero, A. Gaddi, et al.. (2004). A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome. Diabetes Research and Clinical Practice. 69(1). 5–13. 60 indexed citations

14.

Gaddi, A., et al.. (2004). Clinical perspectives of anti-inflammatory therapy in the elderly: the lipoxigenase (LOX)/cycloxigenase (COX) inhibition concept. Archives of Gerontology and Geriatrics. 38(3). 201–212. 46 indexed citations

15.

Koblik, Teresa, Jacek Sieradzki, R Sendur, et al.. (2002). The effect of insulin and sulodexide (Vessel Due F) on diabetic foot syndrome. Pilot study in elderly patients. Clinical Diabetology. 3(1). 49–56. 2 indexed citations

16.

Cicero, Arrigo F.G., et al.. (2002). Effects of a New Soy/β-Sitosterol Supplement on Plasma Lipids in Moderately Hypercholesterolemic Subjects. Journal of the American Dietetic Association. 102(12). 1807–1811. 34 indexed citations

17.

Koblik, Teresa, Jacek Sieradzki, R Sendur, et al.. (2001). The effect of insulin and sulodexide (Vessel Due F) on diabetic foot syndrome. Journal of Diabetes and its Complications. 15(2). 69–74. 16 indexed citations

18.

Cicero, Arrigo F.G., et al.. (2000). A suggestion for familial hypercholesterolemia (FH) heterozygosity clinical diagnosis based on epidemiological observations in a large Italian population. International Journal of Cardiology. 74(1). 5–11. 6 indexed citations

19.

Svegliati, Silvia, et al.. (1999). Monounsaturated diet lowers LDL oxidisability in type IIb and type IV dyslipidemia without affecting coenzyme Q₁₀ and vitamin E contents. BioFactors. 9(2-4). 325–330. 6 indexed citations

20.

Gaddi, A., et al.. (1978). Lipoprotein lipase, heparin and fibrinogen correlations. International Journal of Clinical & Laboratory Research. 8. 323–329.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact